Boston Scientific Corp’s recently made public that its EVP & Group Pres, Cardiology Fitzgerald Joseph Michael unloaded Company’s shares for reported $5.8 million on Jun 04 ’25. In the deal valued at $102.88 per share,56,372 shares were sold. As a result of this transaction, Fitzgerald Joseph Michael now holds 178,342 shares worth roughly $19.16 million.
Then, JOSEPH M FITZGERALD bought 56,372 shares, generating $5,799,625 in total proceeds.
Before that, Mahoney Michael F sold 164,443 shares. Boston Scientific Corp shares valued at $17,051,136 were divested by the Chairman, President & CEO at a price of $103.69 per share. As a result of the transaction, Mahoney Michael F now holds 1,476,882 shares, worth roughly $158.63 million.
Leerink Partners initiated its Boston Scientific Corp [BSX] rating to an Outperform in a research note published on June 16, 2025; the price target was $118. A number of analysts have revised their coverage, including Needham’s analysts, who increased its forecast for the stock in mid April from “a Hold” to “a Buy”. Deutsche Bank also remained covering BSX and has increased its forecast on January 10, 2025 with a “Buy” recommendation from previously “Hold” rating. Needham revised its rating on October 18, 2024. It rated BSX as “a Hold” which previously was an “a Buy”.
Price Performance Review of BSX
On Monday, Boston Scientific Corp [NYSE:BSX] saw its stock jump 0.83% to $107.41. Over the last five days, the stock has gained 4.93%. Boston Scientific Corp shares have risen nearly 39.31% since the year began. Nevertheless, the stocks have risen 20.25% over the past one year. While a 52-week high of $107.17 was reached on 06/30/25, a 52-week low of $71.88 was recorded on 04/07/25.
Levels Of Support And Resistance For BSX Stock
The 24-hour chart illustrates a support level at 106.60, which if violated will result in even more drops to 105.78. On the upside, there is a resistance level at 107.88. A further resistance level may holdings at 108.34.
How much short interest is there in Boston Scientific Corp?
A steep rise in short interest was recorded in Boston Scientific Corp stocks on 2025-06-13, growing by 0.74 million shares to a total of 17.49 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 16.75 million shares. There was a rise of 4.24%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 30, 2024 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $90 price target.
